Real-life insights on menstrual cycles and ovulation using big data
Soumpasis et al.
The finding, in our words
Among 32,595 women trying to conceive using a connected home ovulation test, only 12.4% actually had a 28-day cycle despite 25.3% perceiving they did, and over half had cycles varying by 5 days or more. The findings demonstrate that connected home testing reveals substantial individual variation in cycle length and ovulation timing, which could help women better time intercourse for conception.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.
This retrospective case series found that a protocol combining home-based urinary hormone testing with a smartphone application supported fertility management and family planning without unintended pregnancies. The findings suggest that integrating self-collected urinary data with digital tools offers a viable decentralised approach for ovulation prediction.
Daily remote urine hormone monitoring of LH and PdG, together with age and cycle start day, can identify menstrual cycle phase and day with 95% confidence; this supports precise, patient-centric cycle tracking outside clinic settings.
An intensive protocol combining daily at-home saliva collection for ovarian hormones with smartphone-based ecological momentary assessment achieved 85% compliance in 50 female smokers, revealing substantial within- and between-subject heterogeneity in hormone levels, anxiety and nicotine craving. This demonstrates feasibility of decentralised, patient-centric data collection for studying complex comorbidities.
Wrist-worn temperature sensors detected sustained three-day temperature shifts in 82% of 437 menstrual cycles, with the rise occurring on or after ovulation in 86% of cases. Unlike basal body temperature, wrist skin temperature was unaffected by lifestyle factors such as alcohol or sexual activity, indicating potential for reliable, patient-centric fertility tracking.
Menstrual blood offers a noninvasive, patient-centric matrix for detecting endometriosis, cervical cancer, and hormonal disorders through self-collected samples. Wearable in-pad biosensors enabling real-time monitoring and long-term tracking could transform fertility evaluation and early disease detection, though standardisation and large-scale validation remain critical gaps.